On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
ThursdayMar 31, 2022 9:00 am

Hero Technologies Inc. (HENC) Subsidiary Establishes Presence in Booming Colorado Cannabis Market

Cannabis sales in Colorado broke another record last year, topping $2.22 billion in products sold Cannabis is “massive” driver of tax revenue for Colorado, raking in over $423 million last year alone HENC continues to pursue diversification and integration strategy through subsidiary Another record-breaking year for Colorado’s cannabis industry bodes well for Hero Technologies (OTC: HENC). The company anticipates expanding into the booming market via cultivation and dispensary operations through its wholly owned subsidiary, Mile High Green LLC.  Cannabis sales in the state broke another record last year, topping $2.22 billion in products sold, according to the Colorado Department of Revenue (https://ibn.fm/NNChl). This figure…

Continue Reading

ThursdayMar 31, 2022 9:00 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Reiterates Commitment to Operational Excellence, Advancing Berubicin Recognition

In a video message to shareholders, CEO John Climaco detailed the operational and clinical progress made by lead drug candidate Berubicin despite market volatility and share price fluctuations CNS is currently enrolling patients into a potentially pivotal global drug trial of Berubicin for recurrent glioblastoma multiforme Interim analysis of the trial is currently expected as early as the first quarter of 2023, once 30-50% of trial patients have been on the study for six months CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotech company specializing in developing novel treatments for primary and metastatic cancers of the brain and central nervous system,…

Continue Reading

WednesdayMar 30, 2022 2:39 pm

QualityStocksNewsBreaks – LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Poised to Increase Overall Value on the Lightning Network

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, recently deployed additional European routing nodes. “The company’s available European routing nodes include Italy, Sweden, England, Ireland, France, and Germany. Europe contains approximately 43% of all Lightning Network nodes – second to North America,” a recent article reads. Since the November 2021 launch of the first routing node, US-West, LQwD has seen 157 nodes interconnected with more than 158 transaction channels, routing over 10 Bitcoin through these channels. “LQwD’s launch of these additional nodes firmly positions us to increase…

Continue Reading

WednesdayMar 30, 2022 2:27 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 24th Patent Sets the Stage for New Market Opportunities in Australia

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, celebrated the receipt of its 24th granted patent entitled “Compositions Infused with Nicotine Compounds and Methods of Use Thereof.” Granted in Australia, this is the first patent awarded from the company’s 8th patent family. “The new patent expands on the company’s international IP rights to apply DehydraTECH(TM) technology to most forms of nicotine, namely sprays, gums, lozenges, pouches, capsules, tablets, and pills. It also covers multiple disparate forms of nicotine, including polymer resins of nicotine, freebase nicotine and other nicotine complexes,” reads a recent article. Prior to the…

Continue Reading

WednesdayMar 30, 2022 1:46 pm

QualityStocksNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Releases Spring 2022 Robot Roadshow Schedule

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, has announced its spring 2022 Robot Roadshow schedule. Designed to be an engaging experiential event that allows Knightscope to connect with potential clients and showcase its proprietary crime-fighting robots, the Robot Roadshow will begin on April 12, 2022, and will tour 10 states, including Minnesota, Wisconsin, Illinois, Indiana and Ohio, with 35 scheduled stops. The roadshow will also be in Washington, D.C. during National Police Week. Creative marketing events such as the Robot Roadshow allow KSCP, a public safety innovator, to educate existing and…

Continue Reading

WednesdayMar 30, 2022 1:34 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) to Host LD Micro Invitational at Four Seasons Westlake Village

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced that it will host the 2022 LD Micro Invitational. The prominent three-day investor conference is slated to take place on June 7-9, 2022, at the Four Seasons Hotel Westlake Village, California. Approximately 200 companies from all over the world will showcase what makes them truly special at the event, each presenting for 25 minutes and finalizing their exhibition with private meetings. SRAX will soon release the link to register for virtual and physical components of the…

Continue Reading

WednesdayMar 30, 2022 12:58 pm

QualityStocksNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Subsidiary Expands Treatment Options to Add FDA-Approved Esketamine Nasal Spray

Delic Holdings’ (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) subsidiary, Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S., has expanded its treatment options to include SPRAVATO(R) nasal spray. KWC clinics located in Houston, Las Vegas and Seattle will begin offering this treatment option on April 1. According to the announcement, SPRAVATO is taken with an oral antidepressant and is the first FDA-approved esketamine nasal spray for adults with treatment-resistant depression (“TRD”) or to treat depressive symptoms in adults with major depressive disorder (“MDD”) with suicidal thoughts or actions. Patients interested in the treatment option will first undergo…

Continue Reading

WednesdayMar 30, 2022 12:33 pm

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Announces Expansion of Cannabis Delivery Business, New Distribution Model with Dining Partnership

Sugarmade (OTC: SGMD), an emerging leader in the vertically integrated cannabis marketplace based in California, has signed two definitive agreements designed to expand the company’s footprint. One of the agreements establishes SGMD’s majority ownership in a fully licensed new Hollywood cannabis delivery hub on Strip as well as a minority stake in an expanding reservation-only restaurant brand that offers a private event space that allows cannabis consumption. The announcement also noted that SGMD will have majority ownership in a brand-new cannabis retail distribution hub offering delivery in the affluent neighborhoods of the West Hollywood Hills. Sugarmade also inked a deal…

Continue Reading

WednesdayMar 30, 2022 12:02 pm

QualityStocksNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) CEO Slated to Present Keynote at Upcoming Plant Medicine Week Conference

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, will be participating in the Plant Medicine Week conference, which is scheduled to be held April 5–8, 2022, in Malta. Flora Growth chair and CEO Luis Merchan is the keynote speaker at the four-day event. Merchan’s presentation, titled “Malta — The Gateway to South American and European Cannabis Relations,'' is slated to start at 2:30 CET and will focus on the opportunity presented by Malta’s standpoint on cannabis as well as the cost advantages of South American cultivation and the broader European opportunity. The…

Continue Reading

WednesdayMar 30, 2022 11:51 am

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Initiates Coverage with InvestorBrandNetwork

Silo Pharma (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, has partnered with InvestorBrandNetwork (“IBN”) for its corporate communications. IBN is a multifaceted financial news and publishing company focused on private and public entities. Silo works to develop innovative solutions that address serious conditions such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease and other rare neurological disorders. The company is committed to identifying and partnering with leading medical universities; SILO provides invaluable financial resources to develop safe therapeutic treatments while advancing research through clinical stage studies and trials and into…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered